@article{a632318f25764016902172b3aa4c399f,
title = "Climate change, the environment, and rhinologic disease",
abstract = "Background: The escalating negative impact of climate change on our environment has the potential to result in significant morbidity of rhinologic diseases. Methods: Evidence based review of examples of rhinologic diseases including allergic and nonallergic rhinitis, chronic rhinosinusitis, and allergic fungal rhinosinusitis was performed. Results: The lower socioeconomic population, including historically oppressed groups, will be disproportionately affected. Conclusions: We need a systematic approach to improve healthcare database infrastructure and funding to promote diverse scientific collaboration to address these healthcare needs.",
keywords = "air pollution, allergic fungal rhinosinusitis, allergic rhinitis, chronic rhinosinusitis, climate change, health disparities, nonallergic rhinitis",
author = "Jean Kim and Waugh, {Darryn W.} and Zaitchik, {Benjamin F.} and Amber Luong and Regan Bergmark and Kent Lam and Lauren Roland and Joshua Levy and Lee, {Jivianne T.} and Cho, {Do Yeon} and Murugappan Ramanathan and Fuad Baroody and Mas Takashima and Daniel O'Brien and Lin, {Sandra Y.} and Stephanie Joe and Chaaban, {Mohamad R.} and Anna Butrymowicz and Stephanie Smith and Warren Mullings",
note = "Funding Information: Jean Kim has grant funding from Genentech and GSK and has been a consultant for GSK. Regan Bergmark has grant funding from I‐Mab Biopharma. Amber Luong is a consultant for Lyra Therapeutics, Medtronics, Sanofi, and Stryker; and has served on the advisory board for ENTvantage Cx, Soundhealth, and Maxwell Biosciences. Kent Lam is a speaker for Optinose. Lauren Roland serves on the advisory board of GSK. Joshua Levy serves on the advisory board for GSK, Regeneron, and Honeywell International. Jiviannee Lee is a consultant for Medtronic, Stryker, Aerin, and Sanofi. Mas Takashima is a consultant for Aerin, Acclarent, Medtronic, and LivaNova. Mohamad Chaaban serves on the advisory board for Optinose. All other authors declare no conflicts of interest. Funding Information: We thank the members of the Allergy and Immunology Section of the American Rhinologic Society for their feedback. The views and ideas in this work represent those of the authors and do not necessarily represent the official policy or position of the American Rhinologic Society. Publisher Copyright: {\textcopyright} 2022 The Authors. International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.",
year = "2023",
month = may,
doi = "10.1002/alr.23128",
language = "English",
volume = "13",
pages = "865--876",
journal = "International Forum of Allergy and Rhinology",
issn = "2042-6976",
number = "5",
}